- Home
- CENT vs DNLI Comparison
CENT vs DNLI Comparison
Compare CENT & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CENT
- DNLI
- Stock Information
- Founded
- CENT 1955
- DNLI 2013
- Country
- CENT United States
- DNLI United States
- Employees
- CENT N/A
- DNLI N/A
- Industry
- CENT Consumer Specialties
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CENT Consumer Discretionary
- DNLI Health Care
- Exchange
- CENT Nasdaq
- DNLI Nasdaq
- Market Cap
- CENT 2.2B
- DNLI 2.1B
- IPO Year
- CENT N/A
- DNLI 2017
- Fundamental
- Price
- CENT $36.27
- DNLI $14.46
- Analyst Decision
- CENT Strong Buy
- DNLI Strong Buy
- Analyst Count
- CENT 2
- DNLI 15
- Target Price
- CENT $42.50
- DNLI $33.85
- AVG Volume (30 Days)
- CENT 66.6K
- DNLI 1.7M
- Earning Date
- CENT 08-06-2025
- DNLI 08-11-2025
- Dividend Yield
- CENT N/A
- DNLI N/A
- EPS Growth
- CENT N/A
- DNLI N/A
- EPS
- CENT 2.14
- DNLI N/A
- Revenue
- CENT $3,120,375,000.00
- DNLI N/A
- Revenue This Year
- CENT $0.42
- DNLI N/A
- Revenue Next Year
- CENT $1.15
- DNLI $323.34
- P/E Ratio
- CENT $16.97
- DNLI N/A
- Revenue Growth
- CENT N/A
- DNLI N/A
- 52 Week Low
- CENT $31.97
- DNLI $10.57
- 52 Week High
- CENT $43.88
- DNLI $33.33
- Technical
- Relative Strength Index (RSI)
- CENT 44.43
- DNLI 53.04
- Support Level
- CENT $33.38
- DNLI $12.92
- Resistance Level
- CENT $37.09
- DNLI $15.06
- Average True Range (ATR)
- CENT 1.40
- DNLI 0.78
- MACD
- CENT -0.48
- DNLI 0.06
- Stochastic Oscillator
- CENT 40.70
- DNLI 72.03
About CENT Central Garden & Pet Company
Central Garden & Pet Co understands that home is central to life and has nurtured happy and healthy homes for over forty years. The segments of the company are the pet segment and garden segment. The company's trusted products are dedicated to helping lawns grow greener, gardens bloom bigger, pets live healthier and communities grow stronger. Central is home to a portfolio of more than sixty-five brands including Pennington, Nylabone, Kaytee, Amdro, and Aqueon, manufacturing and distribution capabilities, and a passionate, entrepreneurial growth culture. Central Garden and Pet is based in Walnut Creek, California, and has offices across North America and Europe.
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.